People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endocyte Inc | — | Biotechnology | Series B | $53.7M | $321.5M | 2010 |
Douglas G. Bailey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas G. Bailey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fred A. Middleton | 1 | 9 |
| Mike Sherman | 1 | 6 |
| Ann F. Hanham | 1 | 3 |
| John C. Aplin | 1 | 2 |
| Philip S. Low | 1 | 2 |
| Keith E. Brauer | 1 | 2 |
| James S. Shannon | 1 | 2 |
| John C. Clawson | 1 | 1 |
| Keith B. Brauer | 1 | 1 |
| Jack B. Clawson | 1 | 1 |
| Keith Brauer | 1 | 1 |
| Michael A. Sherman | 1 | 1 |
| Jack Clawson | 1 | 1 |
| Mike A. Sherman | 1 | 1 |
| P. Ron Ellis | 1 | 1 |
| Douglas B. Bailey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.